Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory bowel disease pathogenesis: therapeutic implications.

Claudio Fiocchi1

  • 1Division of Gastroenterology, University Hospitals of Cleveland, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. cxf18@po.cwru.edu

Chinese Journal of Digestive Diseases
|January 26, 2005
PubMed
Summary

Inflammatory bowel disease (IBD) pathogenesis is complex. Current treatments focus on microbial and immune factors, but combination therapies targeting multiple factors may be more effective for IBD.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trained immunity: Breaking a dogma and a missing opportunity in IBD?

Inflammatory bowel diseases·2026
Same author

Gastroenterologists' attitudes and challenges toward treat-to-target strategies in inflammatory bowel disease: a multinational survey.

Therapeutic advances in gastroenterology·2025
Same author

Towards IBD Prediction and Prevention: The Contribution of Genetics and Genomics.

Inflammatory bowel diseases·2025
Same author

Rewiring of Transcription Factor Binding: Another Piece of the Intricate Puzzle of IBD Pathogenesis.

Inflammatory bowel diseases·2025
Same author

The functional role of the extracellular matrix in inflammatory bowel disease associated gut fibrosis.

Matrix biology : journal of the International Society for Matrix Biology·2025
Same author

Cellular and molecular mechanisms in the pathogenesis of pouchitis: more than just the microbiota.

Gut·2025

Area of Science:

  • Gastroenterology
  • Immunology
  • Microbiology

Background:

  • Inflammatory bowel disease (IBD) pathogenesis involves complex interactions between environmental, genetic, microbial, and immune factors.
  • The precise contribution of each factor to IBD development and manifestation remains unclear.
  • Environmental and genetic factors present significant challenges for therapeutic targeting.

Purpose of the Study:

  • To review the current understanding of IBD pathogenesis.
  • To identify the most viable targets for therapeutic intervention in IBD.
  • To explore potential future treatment strategies for IBD.

Main Methods:

  • Literature review of IBD pathogenesis.
  • Analysis of current therapeutic strategies for IBD.

Related Experiment Videos

  • Discussion of microbial and immune system modulation for IBD treatment.

    • Main Results:

    • Microbial and immune factors are the primary targets for current IBD treatments.
    • Modulating the gut microbiota through antibiotics, probiotics, or diet shows therapeutic potential.
    • Inhibiting pro-inflammatory molecules, such as tumor necrosis factor-alpha, is a key strategy in current IBD drug development.

    Conclusions:

    • Microbial and immune factors are the most practical targets for IBD therapeutic interventions.
    • Targeting specific cytokines like tumor necrosis factor-alpha is a significant focus of current IBD pharmacotherapy.
    • Combination therapies addressing multiple pathogenic components are anticipated to yield superior outcomes for IBD management compared to single-target approaches.